Stock Taper 
ECOR1 CAPITAL, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Pharvaris N.V. | PHVS | 235K | $8.13M |
 Nurix Therapeutics, Inc. | NRIX | 270K | $6.55M |
 Erasca, Inc. | ERAS | 330K | $6.05M |
 Odyssey Therapeutics, Inc. | ODTX | 555.55K | $10.39M |
 Phathom Pharmaceuticals, Inc. | PHAT | 625K | $6.78M |
 Relay Therapeutics, Inc. | RLAY | 697.95K | $13.06M |
 Stoke Therapeutics, Inc. | STOK | 735K | $24.05M |
 Zenas BioPharma, Inc. | ZBIO | 789.5K | $20.04M |
 Legend Biotech Corporation | LEGN | 800K | $23.1M |
 CRISPR Therapeutics AG | CRSP | 1.39M | $75.77M |
 CG Oncology Inc. | CGON | 1.49M | $106.17M |
 Atara Biotherapeutics, Inc. | ATRA | 1.55M | $17.82M |
 Aura Biosciences, Inc. | AURA | 1.67M | $11.83M |
 Eton Pharmaceuticals, Inc. | ETON | 2.17M | $78.62M |
 First Tracks Biotherapeutics Inc | TRAX | 3.17M | $63.87M |
 Aktis Oncology, Inc. | AKTS | 4.82M | $155.49M |
 ORIC Pharmaceuticals, Inc. | ORIC | 6.73M | $72.87M |
 AnaptysBio, Inc. | ANAB | 7.88M | $531.91M |
 Zymeworks Inc. | ZYME | 22.97M | $600.45M |